Latest filing published 05 Aug 2020 for Insight Molecular Diagnostics Inc., €5,568.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +183.1%Entry US$36.60 · Close at T+365 US$103.60
- -31.8%Entry US$42.80 · Close at T+365 US$29.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tony T. Kalajian: trading record in brief
Tony T. Kalajian is a declared insider of Insight Molecular Diagnostics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 13 September 2019 to 3 August 2020, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €23k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2020, the count stands at 1 purchase and no sales.
On 5 August 2020 came the latest disclosure, an open-market purchase for €5,568 in Insight Molecular Diagnostics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tony T. Kalajian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.31100.0% of flowCommon Stock, no par valueSEC:0001493152-20-014770:0Canonical exit: 1 Nov 2020 (T+90)
- 10,000 shares@ US$1.9876.3% of flowCommon Stock, no par valueSEC:0001209191-19-049683:0Canonical exit: 12 Dec 2019 (T+90)
2 of 2 declarations
